{"schema_version":"secwatch.filing_event.v1","accession":"0001793229-22-000114","form_type":"8-K","ticker":"CTEV","cik":"0001793229","company_name":"Claritev Corp","filed_at":"2022-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.144697+00:00","generated_at":"2026-06-22T04:17:46.368979+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"MultiPlan Q3 revenue down 13% to $250.5M; net income falls 75%; slashes FY2022 guidance","bullets":["Q3 revenue $250.5M (down 13.1% YoY); net income $19.7M (down 74.8%); adjusted EBITDA $172.2M (down 21.2%).","FY2022 revenue guidance cut to $1,075-1,090M from $1,160-1,200M; adjusted EBITDA lowered to $765-780M from $850-875M.","Drivers: softer patient utilization and unfavorable mix of medical cost savings; COVID impact estimated at $4-6M revenue.","Free cash flow $88.2M vs $146.6M in Q3 2021, down 40%.","Q4 2022 outlook: revenue $235-250M, adjusted EBITDA $155-170M."],"urls":{"canonical":"https://secwatch.observer/filing/0001793229-22-000114","json":"https://secwatch.observer/filing/0001793229-22-000114.json","markdown":"https://secwatch.observer/filing/0001793229-22-000114.md","text":"https://secwatch.observer/filing/0001793229-22-000114.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1793229/000179322922000114/0001793229-22-000114-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1793229/000179322922000114/mpln-20221108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T04:17:46.368979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c099216ec4aa5cb8d2419428bf0f76dc232d57fd","claim":"Claritev Corp reported quarter ended September 30, 2022 results: revenue $250.5 million, net income $19.7 million. Guidance lowered.","evidence_excerpt":"MultiPlan Reports Third Quarter 2022 Results and Updates 2022 Guidance – Q3 2022 Revenues of $250.5 million, Net Income of $19.7 million, and Adjusted EBITDA of $172.2 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1793229/000179322922000114/0001793229-22-000114-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended September 30, 2022"},{"label":"Revenue","value":"$250.5 million"},{"label":"Net income","value":"$19.7 million"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}